Daniel L. Baker

7.1k total citations · 1 hit paper
88 papers, 5.7k citations indexed

About

Daniel L. Baker is a scholar working on Molecular Biology, Rheumatology and Physiology. According to data from OpenAlex, Daniel L. Baker has authored 88 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 19 papers in Rheumatology and 12 papers in Physiology. Recurrent topics in Daniel L. Baker's work include Sphingolipid Metabolism and Signaling (37 papers), Rheumatoid Arthritis Research and Therapies (18 papers) and Receptor Mechanisms and Signaling (16 papers). Daniel L. Baker is often cited by papers focused on Sphingolipid Metabolism and Signaling (37 papers), Rheumatoid Arthritis Research and Therapies (18 papers) and Receptor Mechanisms and Signaling (16 papers). Daniel L. Baker collaborates with scholars based in United States, Japan and Belgium. Daniel L. Baker's co-authors include Abby L. Parrill, Gábor Tigyi, E. William St. Clair, Joan M. Bathon, Gábor Tigyi, Paul Emery, Josef S Smolen, Désirée van der Heijde, Edward Keystone and Ravinder N. Maini and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Circulation.

In The Last Decade

Daniel L. Baker

86 papers receiving 5.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

2004 940 citations Daniel L. Baker et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Daniel L. Baker	2.7k	1.7k	1.2k	924	632	88	5.7k
Jasbir Seehra	3.0k 1.1×	432 0.3×	1.2k 1.0×	1.5k 1.6×	481 0.8×	65	6.4k
John Hood	4.2k 1.5×	503 0.3×	648 0.6×	781 0.8×	769 1.2×	56	7.2k
B A Kamen	2.1k 0.8×	1.1k 0.6×	255 0.2×	532 0.6×	760 1.2×	57	4.7k
Y. Eugene Chin	4.2k 1.6×	229 0.1×	2.1k 1.8×	151 0.2×	313 0.5×	99	7.7k
Pirkko Vihko	3.2k 1.2×	357 0.2×	563 0.5×	111 0.1×	684 1.1×	179	7.3k
Manohar Ratnam	2.8k 1.1×	1.2k 0.7×	556 0.5×	485 0.5×	199 0.3×	103	5.5k
Diana Whitaker‐Menezes	6.1k 2.2×	240 0.1×	944 0.8×	208 0.2×	1.2k 1.9×	93	9.4k
Larry H. Matherly	4.0k 1.5×	3.0k 1.7×	341 0.3×	1.2k 1.3×	145 0.2×	203	7.5k
Norihiro Tada	1.6k 0.6×	337 0.2×	451 0.4×	119 0.1×	309 0.5×	201	5.8k
Xinxin Song	5.3k 2.0×	97 0.1×	776 0.7×	338 0.4×	272 0.4×	81	8.9k

Countries citing papers authored by Daniel L. Baker

Since Specialization

Citations

This map shows the geographic impact of Daniel L. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Baker more than expected).

Fields of papers citing papers by Daniel L. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Baker. The network helps show where Daniel L. Baker may publish in the future.

Co-authorship network of co-authors of Daniel L. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Baker. A scholar is included among the top collaborators of Daniel L. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Baker. Daniel L. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bumgardner, Joel D., et al.. (2021). In vitro evaluation of loaded chitosan membranes for pain relief and infection prevention. Journal of Biomedical Materials Research Part B Applied Biomaterials. 109(11). 1735–1743. 11 indexed citations

Baker, Daniel L., et al.. (2019). A benchmark study of loop modeling methods applied to G protein-coupled receptors. Journal of Computer-Aided Molecular Design. 33(6). 573–595. 16 indexed citations

Baker, Daniel L., et al.. (2017). G protein-coupled receptors: the evolution of structural insight. AIMS Biophysics. 4(3). 491–527. 58 indexed citations

Norman, Derek D., et al.. (2016). Discovery and synthetic optimization of a novel scaffold for hydrophobic tunnel-targeted autotaxin inhibition. Bioorganic & Medicinal Chemistry. 24(19). 4660–4674. 7 indexed citations

Singh, W.M., Shiliang Tian, Hongyu Zhou, et al.. (2012). Electrocatalytic and Photocatalytic Hydrogen Production in Aqueous Solution by a Molecular Cobalt Complex. Angewandte Chemie International Edition. 51(24). 5941–5944. 295 indexed citations

Patil, Renukadevi, Jianxiong Liu, Yaohong Wang, et al.. (2011). Benzyl and Naphthalene Methylphosphonic Acid Inhibitors of Autotaxin with Anti‐invasive and Anti‐metastatic Activity. ChemMedChem. 6(5). 922–935. 51 indexed citations

Taylor, Peter C., Christopher T. Ritchlin, Alan M. Mendelsohn, et al.. (2011). Maintenance of Efficacy and Safety with Subcutaneous Golimumab Among Patients with Active Rheumatoid Arthritis Who Previously Received Intravenous Golimumab. The Journal of Rheumatology. 38(12). 2572–2580. 10 indexed citations

Tsukahara, Tamotsu, Ryoko Tsukahara, Yuko Fujiwara, et al.. (2010). Phospholipase D2-Dependent Inhibition of the Nuclear Hormone Receptor PPARγ by Cyclic Phosphatidic Acid. Molecular Cell. 39(3). 421–432. 101 indexed citations

Valentine, William J., Jianxiong Liu, E Shuyu, et al.. (2010). (S)-FTY720-Vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activity. Cellular Signalling. 22(10). 1543–1553. 47 indexed citations

10.

Pham, Truc Chi T., et al.. (2009). Characterization of non-lipid autotaxin inhibitors. Bioorganic & Medicinal Chemistry. 18(2). 769–776. 20 indexed citations

11.

North, E. Jeffrey, Daniel A. Osborne, Peter K. Bridson, Daniel L. Baker, & Abby L. Parrill. (2009). Autotaxin structure–activity relationships revealed through lysophosphatidylcholine analogs. Bioorganic & Medicinal Chemistry. 17(9). 3433–3442. 23 indexed citations

12.

Parrill, Abby L., et al.. (2007). Virtual screening approaches for the identification of non-lipid autotaxin inhibitors. Bioorganic & Medicinal Chemistry. 16(4). 1784–1795. 38 indexed citations

13.

Rashid, Rumana, Bo Liang, Daniel L. Baker, et al.. (2006). Crystal Structure of a Cbf5-Nop10-Gar1 Complex and Implications in RNA-Guided Pseudouridylation and Dyskeratosis Congenita. Molecular Cell. 21(2). 249–260. 130 indexed citations

14.

Fujiwara, Yuko, Akira Tokumura, Daniel L. Baker, et al.. (2005). Identification of Residues Responsible for Ligand Recognition and Regioisomeric Selectivity of Lysophosphatidic Acid Receptors Expressed in Mammalian Cells. Journal of Biological Chemistry. 280(41). 35038–35050. 77 indexed citations

15.

Gududuru, Veeresa, Kui Zeng, Ryoko Tsukahara, et al.. (2005). Identification of Darmstoff analogs as selective agonists and antagonists of lysophosphatidic acid receptors. Bioorganic & Medicinal Chemistry Letters. 16(2). 451–456. 34 indexed citations

16.

Gottlieb, Alice B., Robert J. Evans, Shu Li, et al.. (2004). Şiddetli plak tipi psoriazisde infliksimab indüksiyon tedavisi: Randomize, çift-kör, plasebo kontrollü çalışma. Journal of the American Academy of Dermatology. 1(4). 222–229. 1 indexed citations

17.

Zhang, Chunxiang, Daniel L. Baker, Satoshi Yasuda, et al.. (2004). Lysophosphatidic Acid Induces Neointima Formation Through PPARγ Activation. The Journal of Experimental Medicine. 199(6). 763–774. 165 indexed citations

18.

Gottlieb, Alice B., Robert J. Evans, Shu Li, et al.. (2004). Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology. 51(4). 534–542. 456 indexed citations

19.

Bautista, Debra L., David J. Fischer, Kazuaki Yokoyama, et al.. (2002). Molecular basis for lysophosphatidic acid receptor antagonist selectivity. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1582(1-3). 309–317. 71 indexed citations

20.

Baker, Daniel L., et al.. (2000). Quantitative Analysis of Lysophosphatidic Acid in Human Blood Fractions. Annals of the New York Academy of Sciences. 905(1). 267–269. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact